{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:19:43Z","timestamp":1790083183589,"version":"4.0.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Maranatha Christian University","award":["020\/SK\/AK\/UKM\/III\/2025"],"award-info":[{"award-number":["020\/SK\/AK\/UKM\/III\/2025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-025-02902-2","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T19:15:57Z","timestamp":1752174957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identifying conserved metastatic pathways across cancers through integrated transcriptomic and network analysis"],"prefix":"10.1007","volume":"42","author":[{"given":"Ardo","family":"Sanjaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Windi","family":"Gunadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Ratnawati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Melvern","family":"Susanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael Andry","family":"Mianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"issue":"2","key":"2902_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10549-020-06083-6","volume":"187","author":"R Sharma","year":"2021","unstructured":"Sharma R. Global, regional, national burden of breast cancer in 185 countries: evidence from GLOBOCAN 2018. Breast Cancer Res Treat. 2021;187(2):557\u201367. https:\/\/doi.org\/10.1007\/s10549-020-06083-6.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"2902_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2902_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41591-020-01195-4","volume":"27","author":"K Ganesh","year":"2021","unstructured":"Ganesh K, Massagu\u00e9 J. Targeting metastatic cancer. Nat Med. 2021;27(1):34\u201344. https:\/\/doi.org\/10.1038\/s41591-020-01195-4.","journal-title":"Nat Med"},{"key":"2902_CR4","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186:1564\u201379. https:\/\/doi.org\/10.1016\/j.cell.2023.03.003.","journal-title":"Cell"},{"issue":"1","key":"2902_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"key":"2902_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"2902_CR7","unstructured":"National Cancer Institute. SEER*Explorer: an interactive website for SEER cancer statistics. 2024. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Accessed 21 Aug 2024."},{"key":"2902_CR8","unstructured":"National Cancer Institute. SEER*Explorer: An interactive website for SEER cancer statistics. Surveillance Research Program. 2025. Available from: https:\/\/seer.cancer.gov\/statistics-network\/explorer\/. Accessed 25 Apr 2025."},{"issue":"1","key":"2902_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41392-020-0134-x","volume":"5","author":"J Fares","year":"2020","unstructured":"Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther. 2020;5(1):28. https:\/\/doi.org\/10.1038\/s41392-020-0134-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"2902_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1056\/NEJMcibr2213497","volume":"388","author":"K Ganesh","year":"2023","unstructured":"Ganesh K. Uncoupling metastasis from tumorigenesis. N Engl J Med. 2023;388(7):657\u20139. https:\/\/doi.org\/10.1056\/NEJMcibr2213497.","journal-title":"N Engl J Med"},{"issue":"11","key":"2902_CR11","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19(11):1423\u201337. https:\/\/doi.org\/10.1038\/nm.3394.","journal-title":"Nat Med"},{"issue":"11","key":"2902_CR12","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.3390\/ijms20112767","volume":"20","author":"Y Hao","year":"2019","unstructured":"Hao Y, Baker D, Ten Dijke P. TGF-\u03b2-mediated epithelial-mesenchymal transition and cancer metastasis. Int J Mol Sci. 2019;20(11):2767. https:\/\/doi.org\/10.3390\/ijms20112767.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2902_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s12032-023-02259-4","volume":"41","author":"I Akrida","year":"2023","unstructured":"Akrida I, Mulita F, Plachouri K-M, Benetatos N, Maroulis I, Papadaki H. Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors. Med Oncol. 2023;41(1):20. https:\/\/doi.org\/10.1007\/s12032-023-02259-4.","journal-title":"Med Oncol"},{"issue":"3","key":"2902_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u201396. https:\/\/doi.org\/10.1038\/nrm3758.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7774","key":"2902_CR15","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/s41586-019-1526-3","volume":"573","author":"V Padmanaban","year":"2019","unstructured":"Padmanaban V, Krol I, Suhail Y, Szczerba BM, Aceto N, Bader JS, et al. E-cadherin is required for metastasis in multiple models of breast cancer. Nature. 2019;573(7774):439\u201344. https:\/\/doi.org\/10.1038\/s41586-019-1526-3.","journal-title":"Nature"},{"issue":"7586","key":"2902_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature17038","volume":"529","author":"J Massagu\u00e9","year":"2016","unstructured":"Massagu\u00e9 J, Obenauf AC. Metastatic colonization by circulating tumour cells. Nature. 2016;529(7586):298\u2013306. https:\/\/doi.org\/10.1038\/nature17038.","journal-title":"Nature"},{"issue":"2","key":"2902_CR17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41568-022-00536-4","volume":"23","author":"A Ring","year":"2023","unstructured":"Ring A, Nguyen-Str\u00e4uli BD, Wicki A, Aceto N. Biology, vulnerabilities and clinical applications of circulating tumour cells. Nat Rev Cancer. 2023;23(2):95\u2013111. https:\/\/doi.org\/10.1038\/s41568-022-00536-4.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"2902_CR18","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20(5):576\u201390. https:\/\/doi.org\/10.1016\/j.ccr.2011.09.009.","journal-title":"Cancer Cell"},{"issue":"12","key":"2902_CR19","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1038\/s41556-018-0236-7","volume":"20","author":"DA Lawson","year":"2018","unstructured":"Lawson DA, Kessenbrock K, Davis RT, Pervolarakis N, Werb Z. Tumour heterogeneity and metastasis at single-cell resolution. Nat Cell Biol. 2018;20(12):1349\u201360. https:\/\/doi.org\/10.1038\/s41556-018-0236-7.","journal-title":"Nat Cell Biol"},{"issue":"3\u20134","key":"2902_CR20","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10555-013-9420-1","volume":"32","author":"J Sceneay","year":"2013","unstructured":"Sceneay J, Smyth MJ, M\u00f6ller A. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 2013;32(3\u20134):449\u201364. https:\/\/doi.org\/10.1007\/s10555-013-9420-1.","journal-title":"Cancer Metastasis Rev"},{"key":"2902_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-024-07428-1","author":"A Sanjaya","year":"2024","unstructured":"Sanjaya A, Ratnawati H, Adhika OA, Rahmatilah FR. The heterogeneity of breast cancer metastasis: a bioinformatics analysis utilizing single-cell RNA sequencing data. Breast Cancer Res Treat. 2024. https:\/\/doi.org\/10.1007\/s10549-024-07428-1.","journal-title":"Breast Cancer Res Treat"},{"key":"2902_CR22","doi-asserted-by":"publisher","DOI":"10.20517\/2394-4722.2019.13","author":"ALB Flynn","year":"2019","unstructured":"Flynn ALB, Schiemann WP. Autophagy in breast cancer metastatic dormancy: tumor suppressing or tumor promoting functions? J Cancer Metastasis Treat. 2019. https:\/\/doi.org\/10.20517\/2394-4722.2019.13.","journal-title":"J Cancer Metastasis Treat."},{"issue":"12","key":"2902_CR23","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/onc.2016.333","volume":"36","author":"EE Mowers","year":"2017","unstructured":"Mowers EE, Sharifi MN, Macleod KF. Autophagy in cancer metastasis. Oncogene. 2017;36(12):1619\u201330. https:\/\/doi.org\/10.1038\/onc.2016.333.","journal-title":"Oncogene"},{"key":"2902_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34890-6","author":"Y Liu","year":"2022","unstructured":"Liu Y, Azizian NG, Sullivan DK, Li Y. mTOR inhibition attenuates chemosensitivity through the induction of chemotherapy resistant persisters. Nat Commun. 2022. https:\/\/doi.org\/10.1038\/s41467-022-34890-6.","journal-title":"Nat Commun"},{"key":"2902_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2019.08.012","volume":"60","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Semin Cancer Biol. 2020;60:14\u201327. https:\/\/doi.org\/10.1016\/j.semcancer.2019.08.012.","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"2902_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41389-021-00355-6","volume":"10","author":"K Xu","year":"2021","unstructured":"Xu K, Wang R, Xie H, Hu L, Wang C, Xu J, et al. Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis. Oncogenesis. 2021;10(10):66. https:\/\/doi.org\/10.1038\/s41389-021-00355-6.","journal-title":"Oncogenesis"},{"issue":"2","key":"2902_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1080\/14737140.2020.1718496","volume":"20","author":"K Stoletov","year":"2020","unstructured":"Stoletov K, Beatty PH, Lewis JD. Novel therapeutic targets for cancer metastasis. Expert Rev Anticancer Ther. 2020;20(2):97\u2013109. https:\/\/doi.org\/10.1080\/14737140.2020.1718496.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"2902_CR28","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10555-023-10131-0","volume":"42","author":"I Khan","year":"2023","unstructured":"Khan I, Steeg PS. A perspective on the metastasis suppressor field. Cancer Metastasis Rev. 2023;42(4):1061\u20133. https:\/\/doi.org\/10.1007\/s10555-023-10131-0.","journal-title":"Cancer Metastasis Rev"},{"issue":"6","key":"2902_CR29","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrclinonc.2011.65","volume":"8","author":"AN Shoushtari","year":"2011","unstructured":"Shoushtari AN, Szmulewitz RZ, Rinker-Schaeffer CW. Metastasis-suppressor genes in clinical practice: lost in translation? Nat Rev Clin Oncol. 2011;8(6):333\u201342. https:\/\/doi.org\/10.1038\/nrclinonc.2011.65.","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"2902_CR30","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s10555-015-9586-9","volume":"34","author":"IJ Fidler","year":"2015","unstructured":"Fidler IJ, Kripke ML. The challenge of targeting metastasis. Cancer Metastasis Rev. 2015;34(4):635\u201341. https:\/\/doi.org\/10.1007\/s10555-015-9586-9.","journal-title":"Cancer Metastasis Rev"},{"key":"2902_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.142277","volume":"308","author":"H Zhang","year":"2025","unstructured":"Zhang H, Sun F, Cao H, Yang L, Yang F, Chen R, et al. UBA protein family: an emerging set of E1 ubiquitin ligases in cancer\u2014a review. Int J Biol Macromol. 2025;308: 142277. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142277.","journal-title":"Int J Biol Macromol"},{"key":"2902_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111919","volume":"134","author":"H Zhang","year":"2025","unstructured":"Zhang H, He X, Yang L, Yang F, Chen R, Wen Z, et al. Trim45: an emerging E3 ubiquitin ligases in cancer. Cell Signal. 2025;134: 111919. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111919.","journal-title":"Cell Signal"},{"key":"2902_CR33","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201606","author":"X Bian","year":"2021","unstructured":"Bian X, Liu R, Meng Y, Xing D, Xu D, Lu Z. Lipid metabolism and cancer. J Exp Med. 2021. https:\/\/doi.org\/10.1084\/jem.20201606.","journal-title":"J Exp Med"},{"issue":"1","key":"2902_CR34","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12964-023-01264-4","volume":"21","author":"S Li","year":"2023","unstructured":"Li S, Sampson C, Liu C, Piao H, Liu H-X. Integrin signaling in cancer: bidirectional mechanisms and therapeutic opportunities. Cell Commun Signal. 2023;21(1):266. https:\/\/doi.org\/10.1186\/s12964-023-01264-4.","journal-title":"Cell Commun Signal"},{"key":"2902_CR35","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.28870406.v1","author":"A Sanjaya","year":"2025","unstructured":"Sanjaya A. Scripts for breast cancer bulk RNA-Seq differential expression, survival, and enrichment analyses using GEO data. 2025. Figshare. https:\/\/doi.org\/10.6084\/m9.figshare.28870406.v1."},{"key":"2902_CR36","doi-asserted-by":"publisher","first-page":"1305644","DOI":"10.3389\/fimmu.2023.1305644","volume":"14","author":"S Najjary","year":"2023","unstructured":"Najjary S, de Koning W, Kros JM, Mustafa DAM. Unlocking molecular mechanisms and identifying druggable targets in matched-paired brain metastasis of breast and lung cancers. Front Immunol. 2023;14:1305644. https:\/\/doi.org\/10.3389\/fimmu.2023.1305644.","journal-title":"Front Immunol"},{"key":"2902_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174070","author":"Y Casablanca","year":"2022","unstructured":"Casablanca Y, Wang G, Lankes HA, Tian C, Bateman NW, Miller CR, et al. Improving risk assessment for metastatic disease in endometrioid endometrial cancer patients using molecular and clinical features: an NRG Oncology\/Gynecologic Oncology Group Study. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14174070.","journal-title":"Cancers (Basel)."},{"issue":"3","key":"2902_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.eururo.2020.06.001","volume":"78","author":"M Kreuz","year":"2020","unstructured":"Kreuz M, Otto DJ, Fuessel S, Blumert C, Bertram C, Bartsch S, et al. ProstaTrend\u2014a multivariable prognostic RNA expression score for aggressive prostate cancer. Eur Urol. 2020;78(3):452\u20139. https:\/\/doi.org\/10.1016\/j.eururo.2020.06.001.","journal-title":"Eur Urol"},{"issue":"4","key":"2902_CR39","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/1878-0261.13158","volume":"16","author":"E Thysell","year":"2022","unstructured":"Thysell E, K\u00f6hn L, Semenas J, J\u00e4remo H, Freyhult E, Lundholm M, et al. Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C. Mol Oncol. 2022;16(4):846\u201359. https:\/\/doi.org\/10.1002\/1878-0261.13158.","journal-title":"Mol Oncol"},{"issue":"1","key":"2902_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13073-021-00956-1","volume":"13","author":"SH Moosavi","year":"2021","unstructured":"Moosavi SH, Eide PW, Eilertsen IA, Brunsell TH, Berg KCG, R\u00f8sok BI, et al. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity. Genome Med. 2021;13(1):143. https:\/\/doi.org\/10.1186\/s13073-021-00956-1.","journal-title":"Genome Med"},{"issue":"1","key":"2902_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41525-021-00223-7","volume":"6","author":"PW Eide","year":"2021","unstructured":"Eide PW, Moosavi SH, Eilertsen IA, Brunsell TH, Langerud J, Berg KCG, et al. Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer. NPJ Genom Med. 2021;6(1):59. https:\/\/doi.org\/10.1038\/s41525-021-00223-7.","journal-title":"NPJ Genom Med"},{"issue":"7","key":"2902_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7): e47.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2902_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8(1):118\u201327. https:\/\/doi.org\/10.1093\/biostatistics\/kxj037.","journal-title":"Biostatistics"},{"issue":"6","key":"2902_CR44","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1093\/bioinformatics\/bts034","volume":"28","author":"JT Leek","year":"2012","unstructured":"Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The SVA package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/bts034.","journal-title":"Bioinformatics"},{"issue":"18","key":"2902_CR45","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway JR, Lex A, Gehlenborg N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics. 2017;33(18):2938\u201340.","journal-title":"Bioinformatics"},{"issue":"2","key":"2902_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1039\/c5mb00663e","volume":"12","author":"G Yu","year":"2016","unstructured":"Yu G, He Q-Y. ReactomePA: an R\/Bioconductor package for reactome pathway analysis and visualization. Mol Biosyst. 2016;12(2):477\u20139. https:\/\/doi.org\/10.1039\/c5mb00663e.","journal-title":"Mol Biosyst"},{"issue":"W1","key":"2902_CR47","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44(W1):W90\u20137. https:\/\/doi.org\/10.1093\/nar\/gkw377.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"2902_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1006701","volume":"15","author":"M Mounir","year":"2019","unstructured":"Mounir M, Lucchetta M, Silva TC, Olsen C, Bontempi G, Chen X, et al. New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. PLoS Comput Biol. 2019;15(3): e1006701. https:\/\/doi.org\/10.1371\/journal.pcbi.1006701.","journal-title":"PLoS Comput Biol"},{"key":"2902_CR49","unstructured":"Therneau TM. A package for survival analysis in R. 2024. Available from: https:\/\/CRAN.R-project.org\/package=survival. Accessed 21 Aug 2024."},{"issue":"9","key":"2902_CR50","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.3390\/cancers15092504","volume":"15","author":"S Modvig","year":"2023","unstructured":"Modvig S, Jeyakumar J, Marquart H, Christensen C. Integrins and the metastasis-like dissemination of acute lymphoblastic leukemia to the central nervous system. Cancers (Basel). 2023;15(9):2504. https:\/\/doi.org\/10.3390\/cancers15092504.","journal-title":"Cancers (Basel)"},{"key":"2902_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145990","volume":"808","author":"J Yu","year":"2022","unstructured":"Yu J, Yang K, Zheng J, Sun X, Zhao W. Establishment of a novel prognostic signature based on an identified expression profile of integrin superfamily to predict overall survival of patients with colorectal adenocarcinoma. Gene. 2022;808: 145990. https:\/\/doi.org\/10.1016\/j.gene.2021.145990.","journal-title":"Gene"},{"issue":"1","key":"2902_CR52","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/exd.14677","volume":"32","author":"L Ni","year":"2023","unstructured":"Ni L, Li P, Li M, Huang S, Dang N. SERPINB8 and furin regulate ITGAX expression and affect the proliferation and invasion of melanoma cells. Exp Dermatol. 2023;32(1):24\u20139. https:\/\/doi.org\/10.1111\/exd.14677.","journal-title":"Exp Dermatol"},{"issue":"2","key":"2902_CR53","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1002\/jcb.27480","volume":"120","author":"J Wang","year":"2019","unstructured":"Wang J, Yang L, Liang F, Chen Y, Yang G. Integrin alpha x stimulates cancer angiogenesis through PI3K\/Akt signalling-mediated VEGFR2\/VEGF-A overexpression in blood vessel endothelial cells. J Cell Biochem. 2019;120(2):1807\u201318. https:\/\/doi.org\/10.1002\/jcb.27480.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2902_CR54","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41419-023-06391-x","volume":"15","author":"M Babamohamadi","year":"2024","unstructured":"Babamohamadi M, Mohammadi N, Faryadi E, Haddadi M, Merati A, Ghobadinezhad F, et al. Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy. Cell Death Dis. 2024;15(1):17. https:\/\/doi.org\/10.1038\/s41419-023-06391-x.","journal-title":"Cell Death Dis"},{"key":"2902_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117534","volume":"249","author":"K Mortezaee","year":"2020","unstructured":"Mortezaee K. CXCL12\/CXCR4 axis in the microenvironment of solid tumors: a critical mediator of metastasis. Life Sci. 2020;249: 117534. https:\/\/doi.org\/10.1016\/j.lfs.2020.117534.","journal-title":"Life Sci"},{"key":"2902_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/978-981-99-4657-0_7","volume-title":"Cytokine and chemokine networks in cancer","author":"MA Mir","year":"2023","unstructured":"Mir MA, Naik AQ, Shah MZUH, Zafar T. CXCL12\u2013CXCR4 axis in cancer metastasis. In: Cytokine and chemokine networks in cancer. Springer Nature Singapore: Singapore; 2023. p. 191\u2013217. https:\/\/doi.org\/10.1007\/978-981-99-4657-0_7."},{"issue":"32","key":"2902_CR57","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1038\/s41388-018-0263-7","volume":"37","author":"DK Ahirwar","year":"2018","unstructured":"Ahirwar DK, Nasser MW, Ouseph MM, Elbaz M, Cuiti\u00f1o MC, Kladney RD, et al. Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene. 2018;37(32):4428\u201342. https:\/\/doi.org\/10.1038\/s41388-018-0263-7.","journal-title":"Oncogene"},{"issue":"10","key":"2902_CR58","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/bjc.2016.104","volume":"114","author":"E Sj\u00f6berg","year":"2016","unstructured":"Sj\u00f6berg E, Augsten M, Bergh J, Jirstr\u00f6m K, \u00d6stman A. Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer. Br J Cancer. 2016;114(10):1117\u201324. https:\/\/doi.org\/10.1038\/bjc.2016.104.","journal-title":"Br J Cancer"},{"key":"2902_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1162787","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, Li H, Yang R, Guo H. Role of the membrane-spanning 4A gene family in lung adenocarcinoma. Front Genet. 2023. https:\/\/doi.org\/10.3389\/fgene.2023.1162787.","journal-title":"Front Genet"},{"key":"2902_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.795844","author":"Y Zeng","year":"2022","unstructured":"Zeng Y, Tan P, Ren C, Gao L, Chen Y, Hu S, et al. Comprehensive analysis of expression and prognostic value of MS4As in glioma. Front Genet. 2022. https:\/\/doi.org\/10.3389\/fgene.2022.795844.","journal-title":"Front Genet"},{"issue":"8","key":"2902_CR61","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.21037\/jtd-21-935","volume":"13","author":"C Chen","year":"2021","unstructured":"Chen C, Guo Q, Tang Y, Qu W, Zuo J, Ke X, et al. Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases. J Thorac Dis. 2021;13(8):5016\u201334. https:\/\/doi.org\/10.21037\/jtd-21-935.","journal-title":"J Thorac Dis"},{"issue":"1","key":"2902_CR62","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jaci.2019.03.001","volume":"144","author":"JT Schroeder","year":"2019","unstructured":"Schroeder JT, Adeosun AA, Do D, Bieneman AP. Galectin-3 is essential for IgE-dependent activation of human basophils by A549 lung epithelial cells. J Allergy Clin Immunol. 2019;144(1):312-315.e1. https:\/\/doi.org\/10.1016\/j.jaci.2019.03.001.","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"2902_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076115","volume":"8","author":"D Luger","year":"2013","unstructured":"Luger D, Yang Y, Raviv A, Weinberg D, Banerjee S, Lee M-J, et al. Expression of the B-cell receptor component CD79a on immature myeloid cells contributes to their tumor promoting effects. PLoS ONE. 2013;8(10): e76115. https:\/\/doi.org\/10.1371\/journal.pone.0076115.","journal-title":"PLoS ONE"},{"issue":"1","key":"2902_CR64","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/pharmrev.121.000381","volume":"74","author":"LM Lucas","year":"2022","unstructured":"Lucas LM, Dwivedi V, Senfeld JI, Cullum RL, Mill CP, Piazza JT, et al. The Yin and Yang of ERBB4: tumor suppressor and oncoprotein. Pharmacol Rev. 2022;74(1):18\u201347. https:\/\/doi.org\/10.1124\/pharmrev.121.000381.","journal-title":"Pharmacol Rev"},{"issue":"5","key":"2902_CR65","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/app12052506","volume":"12","author":"A Kechin","year":"2022","unstructured":"Kechin A, Borobova V, Kel A, Ivanov A, Filipenko M. ErbB4 is a potential key regulator of the pathways activated by NTRK-fusions in thyroid cancer. Appl Sci. 2022;12(5):2506. https:\/\/doi.org\/10.3390\/app12052506.","journal-title":"Appl Sci"},{"key":"2902_CR66","doi-asserted-by":"publisher","DOI":"10.3892\/or.2018.6343","author":"J Xu","year":"2018","unstructured":"Xu J, Gong L, Qian Z, Song G, Liu J. ERBB4 promotes the proliferation of gastric cancer cells via the PI3K\/Akt signaling pathway. Oncol Rep. 2018. https:\/\/doi.org\/10.3892\/or.2018.6343.","journal-title":"Oncol Rep"},{"issue":"7","key":"2902_CR67","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1002\/emmm.201202343","volume":"5","author":"A Mendoza-Naranjo","year":"2013","unstructured":"Mendoza-Naranjo A, El-Naggar A, Wai DH, Mistry P, Lazic N, Ayala FRR, et al. ERBB 4 confers metastatic capacity in Ewing sarcoma. EMBO Mol Med. 2013;5(7):1087\u2013102. https:\/\/doi.org\/10.1002\/emmm.201202343.","journal-title":"EMBO Mol Med"},{"issue":"5","key":"2902_CR68","doi-asserted-by":"publisher","first-page":"3266","DOI":"10.21037\/tcr-19-2132","volume":"9","author":"N Gong","year":"2020","unstructured":"Gong N, Wu R, Ding B, Wu W. ERBB4 promotes the progression of inflammatory breast cancer through regulating PDGFRA. Transl Cancer Res. 2020;9(5):3266\u201373. https:\/\/doi.org\/10.21037\/tcr-19-2132.","journal-title":"Transl Cancer Res"},{"issue":"17","key":"2902_CR69","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/s41388-017-0079-x","volume":"37","author":"F Rauf","year":"2018","unstructured":"Rauf F, Festa F, Park JG, Magee M, Eaton S, Rinaldi C, et al. Ibrutinib inhibition of ERBB4 reduces cell growth in a WNT5A-dependent manner. Oncogene. 2018;37(17):2237\u201350. https:\/\/doi.org\/10.1038\/s41388-017-0079-x.","journal-title":"Oncogene"},{"key":"2902_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113674","volume":"224","author":"S-O Zaraei","year":"2021","unstructured":"Zaraei S-O, Sbenati RM, Alach NN, Anbar HS, El-Gamal R, Tarazi H, et al. Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors. Eur J Med Chem. 2021;224: 113674. https:\/\/doi.org\/10.1016\/j.ejmech.2021.113674.","journal-title":"Eur J Med Chem"},{"issue":"4","key":"2902_CR71","doi-asserted-by":"publisher","first-page":"648","DOI":"10.4161\/15384101.2014.994966","volume":"14","author":"K Canfield","year":"2015","unstructured":"Canfield K, Li J, Wilkins OM, Morrison MM, Ung M, Wells W, et al. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells. Cell Cycle. 2015;14(4):648\u201355. https:\/\/doi.org\/10.4161\/15384101.2014.994966.","journal-title":"Cell Cycle"},{"issue":"3","key":"2902_CR72","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.oooo.2016.04.017","volume":"122","author":"Y Ohashi","year":"2016","unstructured":"Ohashi Y, Kumagai K, Miyata Y, Matsubara R, Kitaura K, Suzuki S, et al. Overexpression of ErbB4 is an independent marker for lymph node metastasis in Japanese patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122(3):313\u201321. https:\/\/doi.org\/10.1016\/j.oooo.2016.04.017.","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"2902_CR73","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.2147\/IJGM.S454421","volume":"17","author":"L Liu","year":"2024","unstructured":"Liu L, Xiao W, Zhang C, Fan P, Zeng J, Yi J. The potential of FOXP3 in predicting survival and treatment response in breast cancer. Int J Gen Med. 2024;17:1233\u201351. https:\/\/doi.org\/10.2147\/IJGM.S454421.","journal-title":"Int J Gen Med"},{"issue":"1","key":"2902_CR74","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3892\/or.2014.3576","volume":"33","author":"G Yang","year":"2015","unstructured":"Yang G, Li H, Yao Y, Xu F, Bao Z, Zhou J. Treg\/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis. Oncol Rep. 2015;33(1):478\u201384. https:\/\/doi.org\/10.3892\/or.2014.3576.","journal-title":"Oncol Rep"},{"issue":"5","key":"2902_CR75","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00262-017-1964-4","volume":"66","author":"A Rathinasamy","year":"2017","unstructured":"Rathinasamy A, Domschke C, Ge Y, B\u00f6hm H-H, Dettling S, Jansen D, et al. Tumor specific regulatory T cells in the bone marrow of breast cancer patients selectively upregulate the emigration receptor S1P1. Cancer Immunol Immunother. 2017;66(5):593\u2013603. https:\/\/doi.org\/10.1007\/s00262-017-1964-4.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"2902_CR76","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1038\/s41467-024-51495-3","volume":"15","author":"L Dong","year":"2024","unstructured":"Dong L, Cao Z, Chen M, Liu Y, Ma X, Lu Y, et al. Inhibition of glycosphingolipid synthesis with eliglustat in combination with immune checkpoint inhibitors in advanced cancers: preclinical evidence and phase I clinical trial. Nat Commun. 2024;15(1):6970. https:\/\/doi.org\/10.1038\/s41467-024-51495-3.","journal-title":"Nat Commun"},{"issue":"3","key":"2902_CR77","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/ijms26030904","volume":"26","author":"D C\u00e1ceres-Calle","year":"2025","unstructured":"C\u00e1ceres-Calle D, Torre-Cea I, Marcos-Zazo L, Carrera-Aguado I, Guerra-Paes E, Berlana-Gal\u00e1n P, et al. Integrins as key mediators of metastasis. Int J Mol Sci. 2025;26(3):904. https:\/\/doi.org\/10.3390\/ijms26030904","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2902_CR78","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-018-0937-3","volume":"18","author":"G S\u00f6keland","year":"2019","unstructured":"S\u00f6keland G, Schumacher U. The functional role of integrins during intra- and extravasation within the metastatic cascade. Mol Cancer. 2019;18(1):12. https:\/\/doi.org\/10.1186\/s12943-018-0937-3","journal-title":"Mol Cancer"},{"issue":"6","key":"2902_CR79","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.3892\/or.2015.3910","volume":"33","author":"M Pickarski","year":"2015","unstructured":"Pickarski M, Gleason A, Bednar B, Duong LT. Orally active \u03b1v\u03b23 integrin inhibitor MK-0429 reduces melanoma metastasis. Oncol Rep. 2015;33(6):2737\u201345. https:\/\/doi.org\/10.3892\/or.2015.3910.","journal-title":"Oncol Rep"},{"issue":"12","key":"2902_CR80","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1007\/s00432-022-04100-3","volume":"148","author":"T Nakagawa","year":"2022","unstructured":"Nakagawa T, Ohta K, Naruse T, Sakuma M, Fukada S, Yamakado N, et al. Inhibition of angiogenesis and tumor progression of MK-0429, an integrin \u03b1v\u03b23 antagonist, on oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2022;148(12):3281\u201392. https:\/\/doi.org\/10.1007\/s00432-022-04100-3.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"2902_CR81","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1743-7563.2009.01266.x","volume":"6","author":"MA Rosenthal","year":"2010","unstructured":"Rosenthal MA, Davidson P, Rolland F, Campone M, Xue L, Han TH, et al. Evaluation of the safety, pharmacokinetics and treatment effects of an \u03b1\u03bd \u03b23 integrin inhibitor on bone turnover and disease activity in men with hormone-refractory prostate cancer and bone metastases. Asia Pac J Clin Oncol. 2010;6(1):42\u20138. https:\/\/doi.org\/10.1111\/j.1743-7563.2009.01266.x.","journal-title":"Asia Pac J Clin Oncol"},{"key":"2902_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.350","author":"K Liao","year":"2023","unstructured":"Liao K, Zhang X, Liu J, Teng F, He Y, Cheng J, et al. The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy. MedComm (Beijing). 2023. https:\/\/doi.org\/10.1002\/mco2.350.","journal-title":"MedComm (Beijing)."},{"issue":"2","key":"2902_CR83","doi-asserted-by":"publisher","first-page":"182","DOI":"10.3390\/membranes12020182","volume":"12","author":"NZ Dur\u00e1n-Saenz","year":"2022","unstructured":"Dur\u00e1n-Saenz NZ, Serrano-Puente A, Gallegos-Flores PI, Mendoza-Almanza BD, Esparza-Ibarra EL, Godina-Gonz\u00e1lez S, et al. Platelet membrane: an outstanding factor in cancer metastasis. Membranes (Basel). 2022;12(2):182. https:\/\/doi.org\/10.3390\/membranes12020182.","journal-title":"Membranes (Basel)"},{"issue":"8060","key":"2902_CR84","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","volume":"640","author":"J Yang","year":"2025","unstructured":"Yang J, Yamashita-Kanemaru Y, Morris BI, Contursi A, Trajkovski D, Xu J, et al. Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity. Nature. 2025;640(8060):1052\u201361. https:\/\/doi.org\/10.1038\/s41586-025-08626-7.","journal-title":"Nature"},{"issue":"5","key":"2902_CR85","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.3390\/cancers13051175","volume":"13","author":"Y Su","year":"2021","unstructured":"Su Y, Tsagkozis P, Papakonstantinou A, Tobin NP, Gultekin O, Malmerfelt A, et al. CD11c-CD8 spatial cross presentation: a novel approach to link immune surveillance and patient survival in soft tissue sarcoma. Cancers (Basel). 2021;13(5):1175. https:\/\/doi.org\/10.3390\/cancers13051175.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2902_CR86","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S1016-8478(23)10765-5","volume":"24","author":"S-A Ju","year":"2007","unstructured":"Ju S-A, Park S-M, Lee S-C, Kwon BS, Kim B-S. Marked expansion of CD11c+CD8+ T-cells in melanoma-bearing mice induced by anti-4-1BB monoclonal antibody. Mol Cells. 2007;24(1):132\u20138. https:\/\/doi.org\/10.1016\/S1016-8478(23)10765-5.","journal-title":"Mol Cells"},{"issue":"5","key":"2902_CR87","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/cjp2.283","volume":"8","author":"C Yuan","year":"2022","unstructured":"Yuan C, Chuang S, Cheng P, Chang K, Wang H, Tsai J, et al. Decreased CD11c-positive dendritic cells in the tumor microenvironment predict double-hit\/triple-hit genotype and survival in diffuse large B-cell lymphoma. J Pathol Clin Res. 2022;8(5):436\u201347. https:\/\/doi.org\/10.1002\/cjp2.283.","journal-title":"J Pathol Clin Res"},{"issue":"11","key":"2902_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004809","volume":"10","author":"KA Williams","year":"2014","unstructured":"Williams KA, Lee M, Hu Y, Andreas J, Patel SJ, Zhang S, et al. A systems genetics approach identifies CXCL14, ITGAX, and LPCAT2 as novel aggressive prostate cancer susceptibility genes. PLoS Genet. 2014;10(11): e1004809. https:\/\/doi.org\/10.1371\/journal.pgen.1004809.","journal-title":"PLoS Genet"},{"key":"2902_CR89","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11272","volume":"9","author":"Y Sui","year":"2021","unstructured":"Sui Y, Lu K, Fu L. Prediction and analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell renal cell carcinoma through bioinformatics analysis. PeerJ. 2021;9: e11272. https:\/\/doi.org\/10.7717\/peerj.11272.","journal-title":"PeerJ"},{"key":"2902_CR90","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2238506","author":"BCY Tse","year":"2023","unstructured":"Tse BCY, Bergamin S, Steffen P, Hruby G, Pavlakis N, Clarke SJ, et al. CD11c + and IRF8 + cell densities in rectal cancer biopsies predict outcomes of neoadjuvant chemoradiotherapy. Oncoimmunology. 2023. https:\/\/doi.org\/10.1080\/2162402X.2023.2238506.","journal-title":"Oncoimmunology."},{"issue":"3","key":"2902_CR91","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jhep.2022.03.039","volume":"77","author":"S Chuah","year":"2022","unstructured":"Chuah S, Lee J, Song Y, Kim H-D, Wasser M, Kaya NA, et al. Uncoupling immune trajectories of response and adverse events from anti-PD-1 immunotherapy in hepatocellular carcinoma. J Hepatol. 2022;77(3):683\u201394. https:\/\/doi.org\/10.1016\/j.jhep.2022.03.039.","journal-title":"J Hepatol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02902-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-025-02902-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-025-02902-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:48:50Z","timestamp":1757220530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12032-025-02902-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":91,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2902"],"URL":"https:\/\/doi.org\/10.1007\/s12032-025-02902-2","relation":{"references":[{"id-type":"doi","id":"10.6084\/m9.figshare.28870406.v1","asserted-by":"subject"}]},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"321"}}